Clinical Genome Resource
Genome Medicine Resources
Primary Funding Sources
ClinGen is primarily funded by the National Human Genome Research Institute (NHGRI), through the following three grants:
- U41 HG006834-01A1
- U01 HG007437-01
- U01 HG007436-01
ClinGen receives support from the National Cancer Institute (NCI) through the following contract:
- HHSN261200800001E
ClinGen also receives funding through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
-
ClinVar is supported by the Intramural Research Program of the NIH, National Library of Medicine.
Investigators
- Adam Buchanan, MS, MPH, CGC
- W. Andrew Faucett, MS, LGC
- David H. Ledbetter, PhD, FACMG
- Christa Lese Martin, PhD, FACMG
- Scott Myers, MD, FAAP
- Erin Rooney Riggs, MS, CGC
- Karen Wain, MS, LGC
- Marc S. Williams, MD
Institutes
Clinical Genome Resource
ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to determining which genetic variants are most relevant to patient care by harnessing both research data and the data from the hundreds of thousands of clinical genetics tests being performed each year, as well as supporting expert curation of these data. In 2013, the National Human Genome Research Institute (NHGRI), along with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Cancer Institute (NCI), awarded over $25 million to support a consortium of research groups to design and implement a framework for evaluating which variants play a role in disease and those that are relevant to patient care.